There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repare Therapeutics (RPTX – Research Report) and TC Biopharm (Holdings) Plc Sponsored ADR (TCBP – Research Report) with bullish sentiments.
Repare Therapeutics (RPTX)
In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Repare Therapeutics, with a price target of $25.00. The company’s shares closed last Wednesday at $9.22, close to its 52-week low of $8.07.
According to TipRanks.com, Burns ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Repare Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $29.75, implying a 221.3% upside from current levels. In a report issued on April 21, Bloom Burton also maintained a Buy rating on the stock with a $49.00 price target.
See today’s best-performing stocks on TipRanks >>
TC Biopharm (Holdings) Plc Sponsored ADR (TCBP)
H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on TC Biopharm (Holdings) Plc Sponsored ADR today and set a price target of $7.00. The company’s shares closed last Wednesday at $1.33, close to its 52-week low of $1.25.
According to TipRanks.com, Kapoor is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for TC Biopharm (Holdings) Plc Sponsored ADR with a $7.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on RPTX:
